Your session is about to expire
← Back to Search
Integrated Care for Opioid Use Disorder and HIV (IMPACT Trial)
IMPACT Trial Summary
This trial will compare the outcomes of 1,350 people who inject drugs receiving methadone maintenance treatment at specialized clinics with those receiving treatment at primary care clinics. The trial will use a stratified, phase-in, cluster-controlled design over 24 months, and will examine the contribution of client, clinician and organizational factors that contribute to the composite primary outcome and individual secondary outcomes. A cost-effectiveness analysis will be conducted to compare the integrated HIV/MMT primary care model with the specialized MMT clinic model.
IMPACT Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.IMPACT Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- Group 1: ECHO-IC/QI-enhanced primary care clinic
- Group 2: Specialty Addiction Clinic
- Group 3: ECHO-IC/QI-enhanced primary care clinic with Pay for Performance
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is recruitment for this investigation still ongoing?
"Clinicaltrials.gov displays that this research project, which was first launched on May 1st 2017, is actively recruiting volunteers. It has recently been updated as of August 12th 2022."
Share this study with friends
Copy Link
Messenger